CRH Medical Acquisition – WELL Health Video Update with Hamed Shahbazi, Chairman and CEO
A WELL Health Video Call Update:
with Hamed Shahbazi
Chairman & CEO of WELL Health:
WELL Announces Major US Expansion, and
$295.5M Equity Offering lead by Mr. Li Ka-shing
See the full interview here:
WELL Health Technologies Corp. (TSX: WELL) (“WELL” or the “Company”), a company focused on consolidating and modernizing clinical and digital assets within the healthcare sector, is pleased to present this virtual update with Hamed Shahbazi, Chairman and CEO of WELL, where he explains WELL's planned US expansion with the proposed acquisition of CRH Medical and how this strategic investment fits into WELL's overarching strategy.
“This is a monumental acquisition for WELL. Once closed it could significantly boost our revenue and EBITDA profile, dramatically enhance our US operations, and further expose us to the massive US market”
In the interview Mr. Shahbazi also discusseswhat it means to WELL and its investors that Hong Kong business leader and billionaire, Mr. Li Ka-Shing is once again leading a major investment in WELL Health.
“For me personally, to be included in Mr. Li’s investment portfolio is a tremendous source of pride and validation that WELL is on an auspiscious path.”
Click Here for the video interview (will update)
About WELL Health Technologies Corp.
WELL is an omni-channel digital health company whose overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health. As such, WELL owns and operates 27 primary healthcare clinics, is Canada's third largest digital Electronic Medical Records (EMR) supplier serving approximately 2,200 healthcare clinics, operates a high quality telehealth services in both Canada and the United States and is a provider of digital health, billing and cybersecurity related technology solutions. WELL is an acquisitive company that follows a disciplined and accretive capital allocation strategy. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and was recognized as a TSX Venture 50 Company three years in a row in 2018, 2019 and 2020. To access the Company's telehealth service, visit: tiahealth.com and for corporate information, visit: www.WELL.company.
About CRH Medical
CRH is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. To date, CRH has completed 30 anesthesia acquisitions, and now serves 69 ambulatory surgical centers in 13 states. In addition, CRH owns the “CRH O'Regan System”, a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves. CRH's O'Regan System is currently used in all 48 lower US states.
For further information:
Pardeep S. Sangha
Vice President Corporate Strategy and Investor Relations